The Japanese journal of surgery

, Volume 13, Issue 4, pp 277–284 | Cite as

Metabolic effect of glucose, insulin and potassium cardioplegia

  • Jun Amano
  • Takao Okamura
  • Makoto Sunamori
  • Akio Suzuki
Original Articles


Glucose-insulin-potassium (GIK) solution is widely used as a cardioplegic infusate for myocardial protection during aortic crossclamping, to obtain rapid diastolic arrest and preservation of energy stores. Nine male patients with aorto-coronary bypass grafting procedure were studied with regard to the metabolic influence of GIK cardioplegia. Hyperglycemia was induced by the infusion of GIK solution for one week after surgery. The serum level of non-esterified fatty acid was high for one week while the triglyceride level was maintained at a high level only in the early post-operative period. Insulin, glucagon and growth hormone which influence carbohydrate and lipid metabolism were also elevated for one week after infusion of GIK solution. We conclude that the derangement of carbohydrate and lipid metabolism which is provoked by the use of GIK cardioplegia normalizes within two weeks after operation.

Key Words

GIK cardioplegia insulin growth hormone glucagon lipid metabolism 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kay, E. B., Nogueira, C., Suzuki, A., Postigo, J. and Mendelson, D.: Myocardial proteiction during aortic valvular surgery. Ann Surg. 154: 159–164. 1961.PubMedCrossRefGoogle Scholar
  2. 2.
    Sunamori, M., Amano, J., Okamura, T. and Suzuki, A.: Superior action of magnesiumlidocaine-1-aspartate cardioplegia to glucoseinsulin-potassium cardioplegia in experimental myocardial protection. Jpn. J. Surg. 12: 372–380, 1982.PubMedCrossRefGoogle Scholar
  3. 3.
    Sodi-Palares, D., Bisteni, A., Medrano, G.A., Testelli, M. R. and DeMicheli, A.: The polarizing treatment of acute myocardial infarction—Possibility of its use in other cardiovascular conditions. Dis. Chest 43: 424–423, 1963.Google Scholar
  4. 4.
    Maroko, P. R., Libby, P., Sobel, B. E., Bloor, C. M., Sybers, H. D., Shell, W. E., Covell, J. W. and Braunwald, E.: Effect of glucoseinsulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation 45: 1160–1175, 1972.PubMedGoogle Scholar
  5. 5.
    Lolley, D. M., Hewitt, R. L. and Drapanas, P.: Retroperfusion of the heart with a solution of glucose, insulin and potassium during anoxic arrest. J. Thorac. Cardiovasc. Surg. 67: 364–370, 1974.PubMedGoogle Scholar
  6. 6.
    Follette, D., Fey, K., Mulder, D., Maloney, J. V. and Buckberg, G. D.: Prolonged safe aortic clamping by combining membrane stabilization, multidose cardioplegia and appropriate pH reperfusion. J. Thorac Cardiovasc. Surg. 74: 682–694, 1977.PubMedGoogle Scholar
  7. 7.
    Bardley, R. D. and Branthwaite, M. A.: Circulatory effects of potassium, glucose and insulin following open-heart surgery. Thorax 25: 716–719, 1970.CrossRefGoogle Scholar
  8. 8.
    Surawicz, B.: Evaluation of treatment of acute myocardial infarction with potassium, glucose and insulin. Progr. Cardiovasc. Dis. 10: 545–560, 1968.CrossRefGoogle Scholar
  9. 9.
    Hewitt, R. L., Woo, R. D., Ryan, J. R. and Drapanas, T.: Plasma insulin and glucose relationships during cardiopulmonary bypass. Surgery 71: 905–921, 1972.PubMedGoogle Scholar
  10. 10.
    Moffit, E. A., Rosevear, J. W., Molnar, G. D. and McGoon, D. C.: Myocardial metabolism in open heart surgery. J. Thorac Cardiovasc. Surg. 59: 691–706, 1970.Google Scholar
  11. 11.
    Boberg, J. and Carlson, L. A.: Determination of heparin induced lipoprotein lipase activity in human plasma. Clin. Chim. Acta. 10: 420–427, 1964.PubMedCrossRefGoogle Scholar
  12. 12.
    Stremmel, W., Schlosser, V., Bartak, A. and Keul, J.: Das Verhalten der Blutlipide bei offenen Herzoperationen mit extracorporaler Zirkulation. Thoraxchirurgie 21: 286–288, 1973.Google Scholar
  13. 13.
    Oyama, T. and Matsuki, A.: Effects of spinal anaesthesia and surgery on carbohydrate and fat metabolism in man. Br. J. Anaesth. 42: 723–729, 1970.PubMedGoogle Scholar
  14. 14.
    Porte, D. Jr.: Sympathetic regulation of insulin secretion. Arch. Int. Med. 123: 252–260, 1969.CrossRefGoogle Scholar
  15. 15.
    Majid, P. A., Ghosh, P., Pakrashi, N. C., Ionescu, M., Dykes, J. R. W. and Taylor, S. H.: Insulin secretion after open-heart surgery with particular respect to pathogenesis of a low cardiac output state. Br. Heart J. 33: 6–11, 1971.PubMedGoogle Scholar
  16. 16.
    Montagomery D. A. D. and Welbourn, R. B.: Medical and Surgical Endocrinology. pp. 13–162, Edward Arnold, London, 1975.Google Scholar
  17. 17.
    Levitsky, L. L. and Levitsky, S.: Hormonal changes affecting carbohydrate metabolism during cardiopulmonary bypass. European Surg. Res. 10: 129–130, 1978.Google Scholar
  18. 18.
    Charters, A. C., Odell, W. D. and Thompson, J. C.: Anterior pituitary function during surgical stress and convalescence. Radioimmunoassay measurement of blood TSH, LH and growth gormone. J. Clin. Endocrinol. 29: 63–71.Google Scholar
  19. 19.
    Yokota, H., Kawashima, Y., Takao, T., Hashimoto, S. and Manabe, H.: Carbohydrate and lipid metabolism in open heart surgery. J. Thorac. Cardiovasc. Surg. 73: 543–549, 1977.PubMedGoogle Scholar
  20. 20.
    Macdonald, R. G., Buckler, J. M. H., Deverall, P. B., Watson, D. A. and Ballint, M.: Growth hormone and blood glucose concentrations during cardiopulmonary bypass. Br. J. Anaesth. 47: 713–718, 1975.PubMedGoogle Scholar
  21. 21.
    Creyer, P. E., Coran, A. G., Keenan, N. S. and Sode, J.: Cessation of growth hormone secretion associated with acute elevation of the serum free-fatty acid concentration. Metabolism 21: 867, 1972.CrossRefGoogle Scholar

Copyright information

© The Japan Surgical Society 1983

Authors and Affiliations

  • Jun Amano
    • 1
  • Takao Okamura
    • 1
  • Makoto Sunamori
    • 1
  • Akio Suzuki
    • 1
  1. 1.Department of Thoracic and Cardiovascular SurgeryTokyo Medical and Dental University, School of MedicineTokyoJapan

Personalised recommendations